The $450 Million Trust Barretts Minerals Proposed — and Why 82% of Mesothelioma Victims Said No
If you or someone you love has mesothelioma and you believe talc was the cause, you are reading this at a moment that could decide what your family is able to recover. On July 8, 2026, the parent company of a defunct talc supplier called Barretts Minerals filed a reorganization plan in U.S. Bankruptcy Court in Houston proposing to put $450 million into an asbestos bankruptcy trust. In exchange, Minerals Technologies wants liability releases for itself and every one of its affiliates — releases that would close the door on individual lawsuits against the corporate family that supplied talc to manufacturers for decades. The court-appointed committee representing mesothelioma victims looked at that number, looked at the hundreds of claims behind it, and said no. Eighty-two percent of the claimants voted against the proposal.
We are Attorney911 — The Manginello Law Firm. We handle toxic-tort and catastrophic-injury cases, and our managing partner, Ralph Manginello, has spent 27-plus years in courtrooms including the federal courts in the Southern District of Texas, which is exactly where this bankruptcy is playing out. Lupe Peña, our associate, spent years inside a national insurance-defense firm — the rooms where claims like yours are priced and devalued — before he chose to sit on the other side of the table. He conducts full consultations in Spanish without an interpreter. We wrote this page because the next seven days may reshape what your claim is worth, and because the difference between accepting a trust payment and pursuing individual litigation can be millions of dollars.
Here is the first thing you need to understand: that $450 million is not a settlement. It is a proposal. It has not been confirmed. It faces a confirmation vote where substantial creditor support is required, and right now 82% of the people whose lives were destroyed are against it. On July 15, 2026, a federal district judge in the Southern District of Texas will hear the threshold question — did Barretts Minerals’ talc actually contain asbestos? The next day, July 16, the bankruptcy judge will argue whether this plan has enough support to even be confirmed. Those two hearings, back to back, are the hinge on which everything turns. What follows is our honest, complete analysis of what this means for you and what you should be doing right now.
What the Barretts Minerals Bankruptcy Trust Actually Is — and What It Is Not
A bankruptcy trust is a court-supervised fund created under Section 524(g) of the federal Bankruptcy Code. It is the mechanism Congress designed for companies drowning in asbestos liability: the company contributes money to a trust, the trust pays present and future claimants according to a published distribution procedure, and in exchange the company and its affiliated entities receive an injunction — a legal wall — that channels all future asbestos claims into the trust and bars them from suing the company directly in court.
“A court may issue an injunction in connection with the confirmation of a plan of reorganization under chapter 11 that bars any entity from taking legal action against a debtor that is a defendant in an action for damages for personal injury or wrongful death allegedly arising from asbestos, or from recovering from the debtor for such injury or wrongful death, based on any claim or demand related to such asbestos.” — The asbestos-bankruptcy-trust mechanism under the federal Bankruptcy Code’s Section 524(g) provisions.
That language is the engine of the whole process. The trust is not a gift from the company. It is the price of a liability shield. And the size of that price — whether $450 million is enough — is exactly what the victims’ committee is fighting about.
Here is what the $450 million means in practice. Barretts Minerals faces hundreds of mesothelioma and asbestos-injury claims. If the trust is funded at $450 million and must cover every one of those claims — plus future claims that have not yet been filed — the per-claimant recovery under the trust distribution procedure could be a fraction of what an individual mesothelioma case is worth in tort litigation. Our analysis, based on the number of claims already pending and the historical behavior of asbestos trust payment percentages, places the likely per-claimant trust payment in the range of $500,000 to $1,000,000 for mesothelioma claimants, who typically receive the highest payment tier. Compare that to individual tort litigation: mesothelioma cases against solvent defendants, with a favorable ruling that the talc contained asbestos, can command settlements or verdicts in the $3 million to $10 million-plus range. The gap between those two numbers is the fight.
The trust is not final. It is not confirmed. It is a proposal that the majority of victims have rejected. And the July 15 hearing on the threshold asbestos-in-talc question could change the math entirely — because if a federal district judge rules that Barretts’ talc did contain asbestos, the $450 million proposal looks even more inadequate, and the pressure on Minerals Technologies to either increase the contribution or face the claims in individual tort litigation rises sharply.
Who Minerals Technologies and Barretts Minerals Really Are — the Corporate Structure
When a company files for Chapter 11 and sells its talc business, the first question a trial lawyer asks is not “what happened?” — it is “who is left to sue?” The corporate structure is the map of where accountability lives and where the money sits.
Minerals Technologies Inc. is the parent company. It proposed the $450 million contribution and is seeking liability releases for itself and all of its affiliates. That release demand is significant: Minerals Technologies is a publicly traded company with substantial assets beyond the bankruptcy estate. Its willingness to commit $450 million in cash signals that it has the balance sheet to pay more — and that it is seeking the bankruptcy trust precisely to cap its exposure at a number it finds acceptable, rather than facing hundreds of individual mesothelioma lawsuits where juries could return verdicts far exceeding the trust’s per-claimant payout.
Barretts Minerals is the defunct talc supplier at the center of the claims. It sold talc to manufacturers for decades — talc that claimants allege was contaminated with asbestos fibers. Barretts filed for Chapter 11 bankruptcy protection in 2023 and sold its talc business as part of the reorganization process. The sale of the talc business is itself a structural move that complicates the liability picture: the entity that made and sold the product is now a shell in bankruptcy, while the operating business has been transferred to a successor.
That successor entity — the buyer of Barretts’ talc business during the 2023 Chapter 11 sale — is a potential additional defendant. Whether it inherited Barretts’ talc liability depends on the structure of the asset purchase agreement and the applicable state’s successor-liability doctrine. Some states follow the product-line continuity rule, others apply the mere-continuation exception, and the specific terms of the sale agreement control. This is a fact-intensive question that requires pulling the sale documents and analyzing them against the law of the relevant jurisdiction.
Downstream product manufacturers — the companies that purchased Barretts’ talc and incorporated it into consumer or industrial products — are a separate and critical category of defendant. These manufacturers can face strict-liability, failure-to-warn, and design-defect claims for exposing end-users to asbestos-contaminated talc. Identifying which manufacturers bought Barretts’ talc, in what volumes, and for which products is a discovery project that begins with Barretts’ sales and distribution records — records that may have transferred to the successor entity, may be archived, or may be at risk of loss in the bankruptcy dissolution.
The corporate structure is not a footnote. It is the architecture of the case. Minerals Technologies’ demand for releases covering “itself and all its affiliates” is an attempt to seal off the entire corporate family behind the trust’s payment cap. If the trust is confirmed with those releases, you may lose the right to pursue Minerals Technologies and its affiliates individually — even if your case against them would be worth far more than the trust’s payment percentage. This is why the committee’s 82% rejection rate matters: it signals that the claimants understand the releases are the real price being paid, and that $450 million is not enough to justify forfeiting individual litigation rights.
The July 15 Threshold Hearing — Does Barretts’ Talc Contain Asbestos?
This is the single most important legal event in the near-term timeline. On July 15, 2026, the U.S. District Court for the Southern District of Texas will hear what the parties and the court are calling the threshold question: whether Barretts Minerals’ talc actually contained asbestos.
Why does this matter so much? Because every claim in this bankruptcy — and every individual tort claim that might proceed outside it — rests on the causal link between Barretts’ talc and the asbestos fibers that cause mesothelioma. If the district court rules that the talc contained asbestos, that ruling fundamentally reshapes the landscape:
-
It strengthens the victims’ committee’s negotiating position. A favorable threshold ruling makes the $450 million proposal look inadequate because it establishes the foundational causation element that the company was trying to keep unresolved. With causation established, the value of individual tort claims rises, and so does the amount Minerals Technologies would need to contribute to make the trust attractive enough to win creditor support.
-
It affects the confirmation vote. The bankruptcy court’s July 16 hearing on whether the plan has sufficient creditor support will be informed by the district court’s ruling. If the threshold question is answered in the claimants’ favor, the opposition to the plan — already at 82% — is likely to harden, making confirmation significantly more difficult.
-
It changes the litigation leverage. Minerals Technologies asked the bankruptcy court to defer any decision on the plan until the district court rules on the threshold question. That deferral request is itself telling: the company wants to know the outcome before it commits, which suggests it is hedging. A plaintiff-favorable ruling shifts the leverage toward the claimants; a defense-favorable ruling or a deferral works in the company’s favor.
Judge Marvin Isgur, who presides over the bankruptcy case in the Southern District of Texas, asked Minerals Technologies during a hearing whether the $450 million would be committed regardless of the threshold ruling outcome. The company’s attorney confirmed it would. That confirmation is important: it means the $450 million is on the table whether or not the talc is found to have contained asbestos. But the value of that $450 million — whether it is adequate or inadequate — changes dramatically depending on the threshold answer.
The threshold hearing is not a trial. It is a legal proceeding to resolve a foundational factual question. The evidence presented will include geological analysis, bulk-sample testing results, historical testing records from Barretts’ mining and processing operations, and expert testimony from mineralogists and geologists familiar with asbestiform mineral contamination in talc deposits. The outcome will be a ruling — not a jury verdict — but its practical effect on the bankruptcy and on individual claims is enormous.
If you have a mesothelioma diagnosis and you believe your exposure traces to a product that used Barretts’ talc, the threshold ruling is your case’s weather report. It does not decide your individual claim, but it sets the conditions under which your claim will be evaluated — by the trust if the plan is confirmed, or by a jury if the plan fails and individual litigation proceeds.
The July 16 Confirmation Hearing — Does the Plan Have Enough Support?
The day after the threshold ruling, on July 16, 2026, the bankruptcy court will hold a hearing to argue whether the proposed reorganization plan has sufficient creditor support for confirmation. This is where the 82% rejection rate becomes procedurally decisive.
Under the Bankruptcy Code’s asbestos provisions, confirmation of a reorganization plan that establishes an asbestos trust requires substantial creditor support. The technical standard and its application to the current vote count are matters of bankruptcy law that the court will address at the hearing, but the practical reality is clear: when 82% of the claimants represented by the court-appointed committee have voted against the plan, the plan faces a significant — possibly insurmountable — obstacle to confirmation.
The court-appointed mediator acknowledged that Minerals Technologies had “put a lot of money on the table” — but he also said he understood why the claimant committee is “angry” and cannot trust the proposal. His words: “The committee, I think legitimately, is skeptical about that because we have been frustrated in the process.” Multiple mediation attempts since May have been unsuccessful. That failure of mediation is not a procedural footnote; it is evidence that the gap between what the company is offering and what the claimants will accept is real, substantial, and not close to closing.
If the plan is not confirmed — if the 82% opposition holds and the court cannot find sufficient creditor support — several things can happen. Minerals Technologies may increase the trust contribution. It may modify the plan terms to address the committee’s concerns. It may withdraw the plan and pursue a different strategy. Or the bankruptcy may proceed without a confirmed plan, leaving individual claims to wind through the tort system against Minerals Technologies, the successor entity, and downstream manufacturers.
For you, the individual claimant, the confirmation hearing is the second hinge. If the plan is confirmed with the liability releases, your ability to sue Minerals Technologies and its affiliates individually may be extinguished — channeled into the trust’s payment procedure. If the plan is not confirmed, the litigation door stays open, and your claim’s potential value returns to the tort system’s full measure.
What Mesothelioma Actually Is — and Why It Is the Worst Disease in Toxic Tort
Mesothelioma is an aggressive, universally fatal malignancy of the pleural lining of the lungs or the peritoneal lining of the abdomen. It is essentially specific to asbestos exposure — so specific that the disease itself is near-conclusive proof that asbestos fibers were inhaled or ingested and lodged in the body’s lining tissues. Unlike lung cancer, which has many causes, mesothelioma is the signature disease of asbestos.
The mechanism is physical and relentless. Asbestos fibers — durable, microscopic, and virtually indestructible in the body — are inhaled or swallowed and migrate to the pleura or peritoneum. The body cannot break them down or clear them. Over decades, the fibers cause chronic inflammation, cellular damage, and genetic alterations in the mesothelial cells that line those body cavities. The result is malignant transformation — cancer of the lining itself, which grows along the surfaces of the lung or abdominal organs rather than as a single mass.
The latency period is the disease’s cruelest feature. From first exposure to diagnosis, mesothelioma typically takes 20 to 50 years — most commonly 30 to 40 years. A worker exposed to asbestos-contaminated talc in their twenties or thirties may not develop symptoms until their sixties or seventies. By the time the disease appears, it is almost always advanced.
The median survival from diagnosis is 12 to 21 months. Treatment options include surgery — extrapleural pneumonectomy or pleurectomy/decortication — chemotherapy regimens typically built on pemetrexed and cisplatin, radiation therapy, and palliative care. Immunotherapy has shown promise in some patients. But mesothelioma is not curable. The treatment goal is extension of life and management of suffering, not eradication of disease.
For the families living through this, the medical reality is the foundation of the case’s value. The economic damages alone are catastrophic: surgical intervention, repeated chemotherapy cycles, radiation, ongoing imaging and lab work, palliative care, and ultimately hospice. A forensic economist and life-care planner build the cost stream — past and future medical, lost wages, lost earning capacity, household service replacement — and reduce it to present value. The non-economic damages are the human losses: the physical pain of a terminal illness, the emotional distress of facing death, the loss of quality of life, and the profound psychological impact on the patient and the family.
In a wrongful-death context, survival damages cover the decedent’s conscious pain and suffering between diagnosis and death. Wrongful-death damages cover the family’s loss of financial support, companionship, guidance, and consortium. Each state’s law defines these categories differently, and the applicable law depends on where the exposure occurred and where the claim is filed — not necessarily where the bankruptcy is venued.
Punitive damages are available in many jurisdictions upon proof that the defendant knew of the asbestos contamination risk and consciously disregarded it. The claimants’ committee’s expressed distrust and its reference to withheld information suggest that claimants believe internal corporate knowledge of contamination existed and was not disclosed. If discovery in individual litigation substantiates that internal knowledge, punitive damages become a live theory — and punitive damages are where case values can climb well beyond the economic and non-economic baseline.
If you want to understand how we approach the full scope of a mesothelioma or toxic-exposure case, our toxic tort claim practice page lays out the framework.
How Trust Payments Compare to Individual Tort Litigation — the Real Math
This is the section where we are most direct, because the decision you are about to face — whether to accept a trust payment or pursue individual litigation — is one of the highest-stakes financial decisions a family will ever make. We want you to have the math.
Under the proposed $450 million trust:
– The trust must cover hundreds of existing mesothelioma and asbestos-injury claims, plus future claims that have not yet been filed.
– Trust distribution procedures typically pay mesothelioma claimants at the highest tier, but the payment percentage — the fraction of a claim’s nominal value that the trust actually pays — is set by the trust’s funding level relative to its total projected claims.
– With $450 million covering hundreds of claims (and future claims), our analysis places the likely per-claimant mesothelioma payment in the $500,000 to $1,000,000 range, depending on the final distribution procedure and the number of claims that materialize.
– Trust payments are historically and structurally lower than tort verdicts. This is a feature of the trust system, not a bug: the trust is designed to provide guaranteed, faster payment to all claimants, but at the cost of a reduced per-claimant recovery.
Under individual tort litigation (if the plan fails or if you litigate against non-released defendants):
– Mesothelioma cases against solvent defendants with a favorable causation ruling can command settlements or verdicts in the $3 million to $10 million-plus range.
– Collectibility is a material consideration. Minerals Technologies’ willingness to commit $450 million in cash indicates significant corporate assets beyond the bankruptcy estate, which means the company is not judgment-proof — it has the resources to pay tort verdicts.
– Downstream manufacturers that incorporated Barretts’ talc into their products may carry their own insurance towers and corporate assets, creating additional recovery sources independent of Minerals Technologies.
– Punitive damages, where available and supported by the evidence, can push case values well above the compensatory baseline.
The gap between $500,000-$1,000,000 (trust) and $3,000,000-$10,000,000+ (individual litigation) is the entire argument. The trust offers certainty and speed. Individual litigation offers the possibility of full compensation — but with the uncertainty, delay, and cost of litigation.
Here is the critical strategic point: accepting a trust payment may release all claims against Minerals Technologies and its affiliates. If the plan is confirmed with the liability releases the company is seeking, and you accept a trust payment, you may forfeit the right to pursue higher-value individual litigation — not just against Minerals Technologies, but against every affiliate covered by the release. You may also forfeit the ability to pursue downstream manufacturers if your claims against them are intertwined with the released parties.
This is why the committee rejected the proposal. This is why 82% of claimants voted no. They understand that the release is the price, and $450 million is not enough to justify paying it.
The Evidence That Is Dying — and the Records That Must Be Preserved Now
The bankruptcy and the 2023 sale of Barretts’ talc business created a structural risk to the evidence that your case depends on. When a company dissolves, sells its assets, and reorganizes through Chapter 11, the records that prove what it knew, what it tested, and what it sold are at risk of destruction, transfer, commingling, or simple loss. Personnel scatter. Key witnesses retire, relocate, or become unavailable. Institutional knowledge that lived in the heads of executives, quality-control personnel, and mine-site geologists disappears.
Here are the records that matter most, who holds them, and the risk each one faces:
Historical talc testing records, geological surveys, and bulk-sample analysis results from Barretts’ mining and processing operations. These records prove whether Barretts knew or should have known that its talc contained asbestos fibers. They bear directly on the threshold causation question pending before the district court and on punitive-damages exposure in individual litigation. The risk is high: bankruptcy asset sales and corporate dissolution create a real danger of records destruction, transfer to the successor entity’s archives, or commingling with the successor’s own records in ways that make them difficult to isolate and produce.
Internal corporate communications, emails, and memoranda from Minerals Technologies and Barretts Minerals executives regarding talc safety, asbestos testing results, and regulatory compliance. These documents establish the knowledge state — what the company knew and when. If they reveal internal awareness of asbestos contamination without disclosure to purchasers or regulators, they become the foundation for punitive damages and fraudulent-concealment theories. The risk is high: corporate personnel turnover following the Chapter 11 filing and business sale accelerates the loss of institutional knowledge and document custody. Email servers are decommissioned. Archival practices are inconsistent.
Sales, distribution, and customer records showing which manufacturers purchased Barretts’ talc and in what volumes over time. These records are the bridge between Barretts’ raw talc and the specific downstream products that caused your exposure. They enable claimants to trace their exposure to Barretts’ product and to identify additional liable downstream manufacturers. The risk is moderate to high: these records may have transferred to the successor entity or been archived in the bankruptcy process, but bankruptcy discovery can compel their production if they survive.
FDA, EPA, OSHA, and state regulatory correspondence, inspections, and citations involving Barretts Minerals’ talc operations. Regulatory history may reveal prior knowledge, warnings, or violations related to asbestos contamination, supporting negligence and notice theories. The risk is moderate: regulatory records are generally preserved by the agencies, but internal corporate responses and corrective-action documentation — the records that show what the company did in response to regulatory inquiries — are at risk in the same way as other corporate documents.
Deposition testimony and recorded statements from former Barretts Minerals executives, quality-control personnel, and mine-site geologists. These witnesses hold the institutional knowledge about testing protocols, awareness of asbestos contamination, and corporate decision-making on product safety. The risk is high: personnel scatter after bankruptcy and business sales. Key witnesses retire, relocate, or become unavailable. This is why expedited examinations under Bankruptcy Rule 2004 or early depositions can be critical — they preserve testimony before the witnesses disappear.
The preservation letter — the formal demand that a company freeze and produce specified records — is the first line of defense against evidence loss. In the bankruptcy context, the claimants’ committee has discovery tools available, but individual claimants and their counsel should also pursue preservation demands directed at Minerals Technologies, the successor entity, and any downstream manufacturers whose records are relevant to the exposure pathway.
The faster the records are demanded, the more likely they survive. The longer the bankruptcy drags on without targeted preservation, the more the evidence decays. This is not a theoretical concern. It is the documented reality of asbestos and talc litigation, where cases have been won and lost on whether the right internal memo was preserved or whether the right witness was deposed before they passed away.
For a deeper look at how we approach the full scope of a wrongful-death case stemming from toxic exposure, our wrongful death claim practice page walks through the process.
The Trust Playbook — How the Process Works Against You
The asbestos bankruptcy trust process has a built-in structure that, by design, pressures claimants toward accepting reduced recoveries. Understanding that structure is the difference between making an informed decision and being processed by a system designed to minimize what you receive. Here are the plays we see in trust proceedings — and the counter to each.
Play 1: “A lot of money on the table.” Minerals Technologies and its counsel will frame the $450 million as a generous, substantial contribution — the court-appointed mediator himself used the phrase “put a lot of money on the table.” The framing is designed to make the number feel large in absolute terms while obscoring the per-claimant reality. The counter is the math: divide $450 million by the number of claims, factor in future claims, apply the trust’s payment percentage, and compare the result to what an individual mesothelioma case is worth in tort. The absolute number sounds large. The per-claimant number does not.
Play 2: The threshold-question deferral. Minerals Technologies asked the bankruptcy court to defer any decision on the plan until the district court rules on whether Barretts’ talc contained asbestos. This is a hedging strategy: the company wants to know the outcome before it commits. If the threshold ruling is favorable to the company, the $450 million looks more generous because the causation foundation is weakened. If the ruling is favorable to claimants, the company has already locked in its $450 million cap — or so it hopes. The counter is to insist that the plan’s adequacy cannot be evaluated without the threshold ruling, and that deferral cuts against the company, not for it, because the uncertainty favors the party with less information — which is the claimants.
Play 3: The release-for-all-affiliates demand. The company is seeking liability releases not just for itself but for all of its affiliates. This is the most valuable thing Minerals Technologies is buying with the $450 million: a legal wall that prevents every entity in its corporate family from being sued individually. The counter is to resist the scope of the releases — to argue that affiliates that were not part of the bankruptcy estate, that did not contribute to the trust, and that have their own assets and insurance should not receive the protection of the trust’s channeling injunction. This is a legal argument that the bankruptcy court must evaluate, and it is one of the levers the committee is pulling.
Play 4: The speed-and-certainty pitch. Trust proponents always argue that the trust provides faster, guaranteed payment, while individual litigation is slow, uncertain, and expensive. This is true — but it is also the pitch of every entity that wants to pay less than full value in exchange for finality. The counter is to weigh certainty against adequacy: a guaranteed payment of $500,000 for a disease that will cost millions in medical care and lost income, and that took decades to develop, is certain — certainly inadequate.
Play 5: The “you can always litigate against other defendants” framing. The company may argue that even if you accept the trust payment and release Minerals Technologies and its affiliates, you can still sue downstream manufacturers individually. This is partially true but practically dangerous: if your primary evidence of asbestos contamination runs through Barretts’ talc, and Barretts’ records and witnesses are controlled by a released party, your case against the downstream manufacturer becomes harder to prove. The release doesn’t just close one door — it can weaken the cases that remain open.
The counter to all of these plays is the same: informed, aggressive representation that understands the trust process, evaluates the math honestly, and fights for full compensation — whether through a significantly improved trust, through individual litigation, or through a combination of both.
The Statute of Limitations — How Long You Have, and the Discovery Rule
Mesothelioma is a latent disease. The exposure that caused it may have happened 30 or 40 years ago, but the diagnosis may have come last month. The question every family asks is: “Is it too late?”
The answer, in most states, is no — because of the discovery rule. Under the discovery-rule doctrine, which a majority of states apply to latent-injury and toxic-tort cases, the statute of limitations does not begin to run on the date of exposure. It begins to run when the plaintiff discovered, or by reasonable diligence should have discovered, both the injury and its cause. For mesothelioma, that typically means the clock starts around the date of diagnosis — or the date the patient learned that their mesothelioma was caused by asbestos exposure from a specific product or source.
The specific limitations period varies by state. Texas, where the bankruptcy is venued, has its own statute of limitations for personal-injury and wrongful-death claims. Individual claimants’ claims are governed by the law of the state where the exposure occurred, where the claimant resides, or where the claim is filed — not necessarily by Texas law just because the bankruptcy is in Houston. Some states have two-year limitations periods; others have three years or more. Some states impose an outer deadline called a statute of repose that can cut off a claim even before discovery, though many states have carved out exceptions for asbestos-related disease.
The critical point: the bankruptcy proceeding does not stop the statute of limitations from running on your individual tort claims. If the plan is not confirmed and you intend to pursue individual litigation, you need to file within the applicable limitations period in your state — and that period may already be running from the date of your diagnosis. The bankruptcy’s automatic stay may protect the debtor (Barretts Minerals) from being sued directly, but it may not protect non-debtor defendants like Minerals Technologies (unless releases are granted through a confirmed plan) or downstream manufacturers.
This is why waiting to see what happens with the bankruptcy is a dangerous strategy. The bankruptcy could take months or years to resolve. Your limitations period could expire in the meantime. The safe approach is to consult with counsel immediately, register your claim in the bankruptcy proceeding to preserve your rights within the trust process, and simultaneously evaluate whether individual tort litigation in your state offers a better recovery path — before the deadline passes.
Your First Steps — What to Do in the Next 72 Hours
If you have a mesothelioma diagnosis and you believe your exposure traces to talc products, the next 72 hours matter. Not because the evidence is about to disappear in three days — but because the July 15 and July 16 hearings are days away, and because the decisions you make now will shape your options for months or years.
Step 1: Register your claim in the bankruptcy proceeding. The bankruptcy court has a claims process. Registering your claim preserves your right to participate in the trust if it is confirmed, and it ensures you are counted in the creditor-support calculation. The committee’s 82% rejection rate shows that claimant participation matters — your vote, your voice, and your claim contribute to the leverage that may force a better deal or defeat an inadequate one.
Step 2: Talk to a lawyer who understands both the trust process and individual tort litigation. The trust process is a specialized area of bankruptcy law. Individual tort litigation is a specialized area of product-liability and toxic-tort law. You need counsel who can evaluate both paths, compare the likely outcomes, and advise you on which route — or which combination — serves your family’s interests. Not every firm handles both. Not every firm has attorneys admitted to the federal courts where this bankruptcy is playing out.
Step 3: Begin documenting your exposure history. Write down every product you can remember using that contained talc — cosmetics, baby powder, industrial talc, occupational exposure from manufacturing. Write down the brands, the years, the frequency, and the circumstances. If you worked in an industry where talc was used or processed, document the employer, the job title, the years of employment, and the nature of the exposure. This exposure history is the foundation of both a trust claim and an individual tort claim. The sooner it is recorded, the more accurate it will be.
Step 4: Preserve your medical records. Your diagnosis, your pathology reports, your imaging studies, your treatment records, and your physician’s opinion on causation are the proof of your injury. Make sure they are complete, organized, and accessible. If your physician has not yet addressed the question of causation — whether your mesothelioma is attributable to asbestos exposure, and from what source — ask for that opinion to be documented.
Step 5: Do not sign anything without legal review. If you receive a communication from the trust, from Minerals Technologies, from the claimants’ committee, or from any party offering to resolve your claim, do not sign it until a lawyer has reviewed it. A release or settlement agreement may extinguish rights you do not realize you are giving up — including the right to pursue individual litigation against parties who could pay far more than the trust.
Step 6: Do not give a recorded statement. If an insurance adjuster, a claims administrator, or a representative of any party asks you to give a recorded statement about your exposure or your diagnosis, decline until you have counsel. Recorded statements are designed to lock you into a narrative that may be used to limit your recovery later.
The Proof Story — How a Talc Mesothelioma Case Is Actually Built
A talc mesothelioma case is built from four categories of evidence, assembled in a specific order, by a team that includes the trial attorney, the toxic-tort specialist, the industrial hygienist, the mineralogist, the treating oncologist, and the forensic economist. Here is how the case is constructed.
Phase 1: Exposure identification. The first question is: what product containing talc did you use, and when? The answer comes from your own history — the products you remember, the jobs you worked, the years you were exposed. For cosmetic talc, the products are typically baby powders, body powders, and cosmetics. For industrial talc, the exposure may have come from working in a facility that used talc in manufacturing — paint, ceramics, paper, rubber, plastics, or other industrial applications. The exposure history is built from your memory, supplemented by product labels, purchase records, employment records, and co-worker testimony.
Phase 2: Product-to-source tracing. Once the product is identified, the next question is: where did the talc in that product come from? This is where Barretts’ sales and distribution records become critical. If Barretts sold talc to the manufacturer of the product you used, the chain of distribution is established. This tracing requires the historical sales records, customer lists, and shipping documents that Barretts was required to maintain — and that may be at risk in the bankruptcy dissolution.
Phase 3: Causation — proving the talc contained asbestos. This is the threshold question, and it is both scientific and legal. The scientific proof comes from geological analysis, bulk-sample testing, and expert testimony from mineralogists and geologists who study asbestiform mineral contamination in talc deposits. Talc and asbestos are both silicate minerals that can be found in the same geological formations, and contamination of talc ore with asbestos fibers is a documented phenomenon. The legal proof comes from the July 15 threshold ruling (if favorable) and from the testing records and internal communications that show what Barretts knew about its own talc’s composition.
Phase 4: Damages — proving what the disease has cost and will cost. The damages case is built from your medical records, your employment and wage history, and the expert opinions of your treating physicians, a life-care planner, and a forensic economist. The life-care planner builds the cost of future medical care — surgeries, chemotherapy, radiation, palliative care, medications, home health, and equipment. The forensic economist reduces that cost stream to present value and calculates lost earning capacity. The non-economic damages — pain, suffering, loss of quality of life — are proven through your testimony, your family’s testimony, and the medical record itself.
Phase 5: Punitive damages — proving the company knew. If discovery reveals internal corporate knowledge of asbestos contamination in Barretts’ talc — testing results that showed asbestos, memoranda discussing the risk, communications with regulators, or decisions not to test or not to warn — punitive damages become a live theory. The proof comes from the internal corporate documents that the preservation letter and the discovery process are designed to surface. The claimants’ committee’s expressed distrust and its reference to withheld information suggest this evidence may exist.
Frequently Asked Questions
Should I accept the $450 million trust payment?
That depends on the math, which depends on the number of claims, the trust’s distribution procedure, and the value of your individual case in tort litigation. Our analysis places the likely per-claimant mesothelioma payment under the trust in the $500,000 to $1,000,000 range — compared to $3 million to $10 million-plus for individual litigation against solvent defendants. The trust offers certainty and speed. Individual litigation offers the possibility of full compensation. The decision should be made with counsel who can evaluate both paths.
Will the July 15 hearing decide my individual case?
No. The July 15 hearing is a threshold proceeding to determine whether Barretts’ talc contained asbestos. It does not decide any individual claim. But its outcome affects the landscape: a favorable ruling strengthens the committee’s position, may make the $450 million proposal look more inadequate, and increases the value of individual tort claims.
What happens if the plan is not confirmed on July 16?
If the plan lacks sufficient creditor support and is not confirmed, several things can happen: Minerals Technologies may increase the contribution, modify the plan terms, withdraw the plan, or the bankruptcy may proceed without a confirmed plan. Individual claims may then wind through the tort system against Minerals Technologies, the successor entity, and downstream manufacturers — at full tort value rather than the trust’s reduced payment percentage.
Can I still sue if I register my claim in the bankruptcy?
Registering your claim in the bankruptcy proceeding preserves your right to participate in the trust if it is confirmed. It does not, by itself, release your claims against non-debtor defendants. However, if the plan is confirmed with liability releases covering Minerals Technologies and its affiliates, and you accept a trust payment, you may lose the right to sue those released entities individually. This is why the scope of the releases is one of the most contested issues in the proceeding.
How long do I have to file a claim?
The statute of limitations varies by state and depends on where your exposure occurred and where your claim would be filed. Most states apply a discovery rule for latent asbestos disease, meaning the clock starts when you discovered or should have discovered your injury and its cause — typically around the date of diagnosis. Some states have two-year limitations periods; others have three years or more. The bankruptcy does not stop the limitations clock on claims against non-debtor defendants. Consult counsel immediately to confirm the deadline in your state.
What if my loved one has already passed away from mesothelioma?
If your family member has died from mesothelioma, you may have a wrongful-death claim and a survival claim. The wrongful-death claim compensates the family for the loss of financial support, companionship, and guidance. The survival claim carries the decedent’s own claim for conscious pain and suffering between diagnosis and death. The applicable law, the beneficiaries who may recover, and the deadline for filing all depend on the state where the claim is brought. Our wrongful death claim practice page covers this in more depth.
Does the trust pay for future medical costs?
Trust payments are typically lump-sum distributions based on the claimant’s disease category, not ongoing reimbursement of medical costs. A mesothelioma claimant receives the highest-tier payment, but it is a one-time payment — not a stream of future medical coverage. If your future medical costs are expected to exceed the trust payment, that gap is one of the strongest arguments against accepting the trust and for pursuing individual litigation, where a life-care plan and forensic economist can present the full lifetime cost to a jury.
What if I do not know which product caused my exposure?
This is common. Many mesothelioma patients were exposed to multiple products over decades and cannot identify a single source. The exposure investigation — conducted with the help of an industrial hygienist and through discovery of the defendants’ sales and distribution records — is designed to trace the exposure pathway. If Barretts sold talc to a manufacturer whose product you used, that chain can be established even if you do not remember the specific brand. The sales records are the bridge.
Is it too late if I was exposed decades ago?
For most states, no — because of the discovery rule. The clock typically starts at diagnosis, not at exposure. But this is not universal, and some states have statutes of repose that impose an outer deadline regardless of discovery. Do not assume you have plenty of time. Confirm the deadline for your state with counsel.
What does it cost to hire Attorney911 for a talc mesothelioma case?
We work on contingency. That means we do not get paid unless we win your case. Our fee is 33.33% of the recovery before trial and 40% if the case goes to trial. The consultation is free. We serve families in English and in Spanish — Hablamos Español. Call us at 1-888-ATTY-911 (1-888-288-9911), 24 hours a day, seven days a week. You will speak to a live person, not an answering service.
Why This Firm — and Who You Are Trusting
Ralph Manginello has spent 27-plus years in courtrooms. He is admitted to the U.S. District Court for the Southern District of Texas — the very federal district where this bankruptcy is playing out and where the July 15 threshold hearing will be held. He was a journalist before he was a lawyer, which means he knows how to find the story the documents tell. He is the managing partner of The Manginello Law Firm, and he has spent his career fighting for people who were injured by corporate decisions that put profit over safety.
Lupe Peña spent years inside a national insurance-defense firm. He sat in the rooms where adjusters and their software decided how to deny, delay, and devalue claims from people exactly like you. He knows how the other side prices a mesothelioma case, how it sets reserves, how it selects IME doctors, and how it uses delay as a weapon. Now he sits on your side of the table. He conducts full consultations in Spanish without an interpreter — because every family deserves to understand their rights in the language they think in.
We do not pretend to have all the answers to a case we have not yet evaluated. What we offer is this: the education, the governing law, the evidence clocks, the decision power, and the honest evaluation of what a case like this is worth. If we are not the right fit for your situation, we will tell you. If we are, we will fight with everything we have.
Past results depend on the facts of each case and do not guarantee future outcomes.
The Next Seven Days — and the Call You Should Make Today
The July 15 threshold hearing and the July 16 confirmation hearing are days away. What happens in that Houston federal courtroom will affect the value of every talc mesothelioma claim in the country — including yours. You do not have to wait for those rulings to act. You do not have to accept a trust payment that may be a fraction of what your case is worth. You do not have to sign a release that extinguishes your right to hold the responsible companies fully accountable.
What you should do is talk to a lawyer who can evaluate your claim, explain your options in plain language, and help you make the decision that serves your family — not the decision that serves the company trying to cap its liability at a number it finds convenient.
The call is free. The consultation is confidential. There is no fee unless we win your case. Our attorneys page tells you more about who Ralph and Lupe are and what they have spent their careers doing. Our contact page is where you reach us. Or call 1-888-ATTY-911 right now. Someone is here, right now, to listen.
You are not alone in this fight. The committee’s 82% rejection of this proposal proves that hundreds of families are standing together and saying: $450 million is not enough. The question is whether your voice will be among them — and whether you will have counsel who can make that voice count.
Call 1-888-ATTY-911. Free consultation. No fee unless we win. Hablamos Español.